Bloomberg News:
My first question is, do you have clear evidence that the Chinese vaccines prevent infection? When will you be rolling them out to other countries that have vaccine deals with China?
Zheng Zhongwei:
I have talked about the effectiveness of the vaccines in my previous response. The Chinese vaccine company reporting the fastest progress in phase III clinical trials has just recently obtained the number of cases required for interim data unblinding and is now providing the relevant materials. The data will be published once it is unblinded.
Regarding your second question, you may remember that at the 73rd World Health Assembly, President Xi Jinping announced that China will make its COVID-19 vaccine a global public good when available, contributing to vaccine accessibility and affordability in developing countries. As such, we have made the relevant arrangements in our vaccine production capacity plans. Thank you.
Hu Kaihong:
Today's press conference ends here. Thank you to the speakers and attendees.
Translated and edited by Zhang Liying, Wang Qian, Lin Liyao, Yang Xi, Wang Yiming, Zhang Junmian, Zhang Jiaqi, Yuan Fang, Liu Jianing, Wang Wei, Li Huiru, David Ball, Jay Birbeck, and Tom Arnstein. In case of any discrepancy between the English and Chinese texts, the Chinese version is deemed to prevail.
